Home > Financial Ratios > PANACEA BIOTEC

PANACEA BIOTEC
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for PANACEA BIOTEC
Please provide your vote to see the results

PANACEA BIOTEC Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -3.53-20.68-1.9011.704.68

What is the latest Core EBITDA Margin ratio of PANACEA BIOTEC ?

The latest Core EBITDA Margin ratio of PANACEA BIOTEC is -3.53 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar2024-3.53
Mar2023-20.68
Mar2022-1.90
Mar202111.70
Mar20204.68

How is Core EBITDA Margin of PANACEA BIOTEC Trending?

Years Core EBITDA Margin % Change
Mar2024 -3.53
Negative
Mar2023 -20.68
Negative
Mar2022 -1.9
Negative
Mar2021 11.7
150.00
Mar2020 4.68 -

Other Financial Ratios of PANACEA BIOTEC


Compare Core EBITDA Margin ratio of peers of PANACEA BIOTEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PANACEA BIOTEC ₹2,584.1 Cr 2.1% 3.7% 197.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,607.0 Cr -5.9% -2.8% -5.3% Stock Analytics
DIVIS LABORATORIES ₹170,148.0 Cr -3.7% -6.9% 30.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,471.0 Cr -3.8% 7.1% 12% Stock Analytics
CIPLA ₹121,103.0 Cr -3.9% -0.8% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹101,306.0 Cr -6% -7.3% -12% Stock Analytics


PANACEA BIOTEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PANACEA BIOTEC

2.1%

3.7%

197.3%

SENSEX

-0.8%

-3.3%

-1.4%


You may also like the below Video Courses